1Nakamura T, Kuioda Y, Yamashita S, et al. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage[J]. Stroke, 2008, 39 (2) : 463- 469.
7Uno M,Kitazato KT,Suzue A,et al. Inhibition of brain damage byedaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction[J]. Free Radic Bio Med. 2005,39(8):1109-1116.
8Amemiya S, Kamiya T, Nito C, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats[J]. Eur J Pharmacol, 2005,516 (2) : 125-130.
9Oishi M,Mochizuki Y, Hara M,et al. Effects of sodium ozagrel on hemostatic markers and cerebral blood flow in lacunar infarction [J]. Clin Neuropharmacol, 1996,19(6) : 526-531.
10Tanahashi N. Antithrombotic therapy in cerebral infarction [J]. Rinsho Shinkeigaku,2000,40(12) :1251-1253.
6Nakamura T, Kuioda Y, Yamashita S. et al. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hem- orrhage [ J ]. Stroke,2008,39:463 - 469.
7Yoshida H. Yanai H. Namiki Y, et aI. Neuropmtective effects of edara- vone:a novel tree radical scavenger in cerebrovascular injury [ J ] , CNS Drug Rev, 2006,12 : 19 - 20.
8Yoshida H, Yanai H, Namiki Y, et al. Neuroprotective effects of edara- vone:a novel free radical scavenger in cerebrovascular injury[ J ]. CNS Drug Rev ,2006,12 : 19 - 20.
